XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2014
Fair Value Measurements [Abstract]  
Schedule of assets measured at fair value on a recurring basis
We measure the following major security types at fair value on a recurring basis. We break down the inputs used to measure fair value for these assets at June 30, 2014 and December 31, 2013 as follows (in thousands):

 
 
At June 30,
2014
  
Quoted Prices in
Active Markets
(Level 1)
  
Significant Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
Cash equivalents
 
$
70,638
  
$
70,638
  
$
  
$
 
Corporate debt securities (1)
  
339,847
   
   
339,847
   
 
Debt securities issued by U.S. government agencies (1)
  
98,373
   
   
98,373
   
 
Debt securities issued by the U.S. Treasury
  
11,264
   
11,264
   
   
 
Debt securities issued by states of the United States and political subdivisions of the states (1)
  
66,391
   
   
66,391
   
 
Investment in Regulus Therapeutics Inc.
  
56,678
   
56,678
   
   
 
Equity securities (2)
  
2,481
   
625
   
   
1,856
 
Total
 
$
645,672
  
$
139,205
  
$
504,611
  
$
1,856
 

 
 
At December 31,
2013
  
Quoted Prices in
Active Markets
(Level 1)
  
Significant Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
 
Cash equivalents
 
$
133,233
  
$
133,233
  
$
  
$
 
Corporate debt securities (1)
  
407,897
   
   
407,897
   
 
Debt securities issued by U.S. government agencies
  
64,432
   
   
64,432
   
 
Debt securities issued by the U.S. Treasury
  
15,328
   
15,328
   
   
 
Debt securities issued by states of the United States and political subdivisions of the states
  
22,255
   
   
22,255
   
 
Investment in Regulus Therapeutics Inc.
  
52,096
   
52,096
   
   
 
Equity securities (2)
  
1,276
   
1,276
   
   
 
Total
 
$
696,517
  
$
201,933
  
$
494,584
  
$
 

(1)Includes investments classified as cash equivalents on our condensed consolidated balance sheet.

(2)Included in other current assets on our condensed consolidated balance sheet.
 
Summary of investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3)
The following is a summary of our investments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended June 30, 2014 (in thousands):
 
 
 
Beginning balance of Level 3 investments
 
$
-
 
   Total gain included in accumulated other comprehensive income (loss)
  
1,856
 
Ending balance of Level 3 investments
 
$
1,856